Through its Impact Grants, the Cancer Research Institute funds projects that aim to advance defined scientific and technological goals. These awards stem from ongoing collaborations with individual donors and nonprofit organizations, and aim to address major challenges that would otherwise limit progress in cancer immunotherapy research and drug development.
The Immunotherapy Promise, a collaboration between the Cancer Research Institute (CRI)and Israel Cancer Research Fund (ICRF), will provide funding for qualified scientists at leading universities and research centers throughout Israel with the goal of advancing our understanding of cancer immunotherapy and developing life-extending therapies, novel diagnostic approaches, and/or prevention strategies.
Learn More
In partnership with Sage Bionetworks (Sage) and the Institute for Systems Biology (ISB), the Cancer Research Institute iAtlas is an online database and web resource designed to help basic and clinical researchers navigate immunological data across multiple tumor types.
Learn More
The Cancer Research Institute (CRI) and the Focused Ultrasound Foundation (FUSF) established a partnership with the goal of advancing the development of new focused ultrasound (FUS) and cancer immunotherapy treatments. Grant projects address critical unanswered research questions that will help move the field towards new device/drug combination therapies.
Learn More
In December 2012, CRI and Stand Up to Cancer (SU2C), announced their co-funding of the Cancer Immunology Translational Research Dream Team, whose research has focused on optimizing immunological checkpoint blockade combined with adoptive T cell transfer, two highly promising approaches to cancer immunotherapy.
Learn More
In 2016, the Cancer Research Institute partnered with the Fibrolamellar Cancer Foundation (FCF), a nonprofit organization devoted to funding research in a rare but deadly form of liver cancer called fibrolamellar hepatocellular carcinoma (FHC), to provide $641,500 to four outstanding scientists whose research is focused on developing immunotherapies for patients with FHC.
Learn More
In 2017, Fight Colorectal Cancer (Fight CRC) and the Cancer Research Institute (CRI) partnered to bring immunotherapy expertise to bear on the challenges of treating Collorectal Cancer. This two-year grant will provide $400,000 to an outstanding scientist whose research will help develop new strategies for effectively treating colorectal cancer patients with immunotherapy.
Learn More